Project Details
Description
Phase Ib and Phase II Studies of anti-PD-1 Antibody MK-3475 in Combination with Bevacizumab for the Treatment of Metastatic renal Cell Carcinoma: Big Ten Cancer Research Consortium BTCRC-GU14-003
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/15 → 12/31/20 |
Funding
- HOOSIER CANCER RESEARCH NETWORK, INC
- MERCK
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.